Literature DB >> 12861528

Endoscopic ligation of esophageal varices for prophylaxis of first bleeding in children and adolescents with portal hypertension: preliminary results of a prospective study.

Danuta Celińska-Cedro1, Mikotaj Teisseyre, Marek Woynarowski, Piotr Socha, Jerzy Socha, Józef Ryzko.   

Abstract

BACKGROUND/
PURPOSE: Endoscopic variceal ligation (EVL) is effective in controlling rebleeding from esophageal varices in children, but there is no data on the use of EVL to prevent initial bleeding. The objective of this study was to prospectively evaluate the efficacy of EVL in preventing the first hemorrhage from esophageal varices in children.
METHODS: Thirty-seven children with portal hypertension (22 liver cirrhosis, 15 portal vein thrombosis), aged 4 to 17 years (M = 9.5 +/- 4.4 years) were included in the study. The criteria for inclusion were (1) no previous variceal bleeding; (2) the presence of esophageal varices classified grade II or more, and (3) their enlargement by at least I grade after 6 months of observation without endoscopic treatment or appearance of endoscopic signs of high bleeding risk. A Multi-Band Ligator was used, and 2 to 6 bands were fixed under general anesthesia during one procedure depending on the number and size of varices. Follow-up examinations were performed every 3 months, repeating the procedure if necessary. In total, 75 procedures of EVL were performed, from one to 5 in each patient
RESULTS: Four patients underwent liver transplantation before eradication of varices. Two others were excluded from the observation because of lack of compliance to the protocol. Of the remaining 31 patients, eradication of varices was achieved in 28 children (90.3%) after 2.0 EVL sessions performed at 3-month intervals. The average time of follow-up after cessation of treatment is 16 months. No bleeding from varices occurred in any child during or after treatment. There were no differences in results between children with liver cirrhosis and portal vein thrombosis. Development of hypertensive gastropathy was observed in 2 children with one episode of bleeding. Recurrence of varices without bleeding occurred in 3 children after 12, 13, and 28 months from eradication.
CONCLUSIONS: The study results confirmed that endoscopic variceal ligation is a safe and highly effective procedure in children with portal hypertension, regardless of its etiology. Eradication of esophageal varices was followed by 16 months free of bleeding. Prolonged observation is mandatory to conclude if preventive EVL influences the natural history of disease and diminishes the risk of first bleeding onset.

Entities:  

Mesh:

Year:  2003        PMID: 12861528     DOI: 10.1016/s0022-3468(03)00181-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  13 in total

Review 1.  Portal vein thrombosis.

Authors:  Yogesh K Chawla; Vijay Bodh
Journal:  J Clin Exp Hepatol       Date:  2015-01-06

Review 2.  Portal hypertension in children.

Authors:  Simon C Ling
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

Review 3.  New approaches to the autosomal recessive polycystic kidney disease patient with dual kidney-liver complications.

Authors:  Grzegorz Telega; David Cronin; Ellis D Avner
Journal:  Pediatr Transplant       Date:  2013-04-17

4.  Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Peter W Angus; Sanjay Saran Baijal; Yogesh Kumar Chawla; Radha Krishna Dhiman; H Janaka de Silva; Saeed Hamid; Shozo Hirota; Ming-Chih Hou; Wasim Jafri; Mobin Khan; Laurentius A Lesmana; Hock F Lui; Veena Malhotra; Hitoshi Maruyama; Debendranath Guha Mazumder; Masao Omata; Ujjal Poddar; Amrinder S Puri; Praveen Sharma; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Hasnain Ali Shah; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2008-09-05       Impact factor: 6.047

Review 5.  Screening and Prophylaxis for Varices in Children with Liver Disease.

Authors:  Molly A Bozic; Kanika Puri; Jean P Molleston
Journal:  Curr Gastroenterol Rep       Date:  2015-07

Review 6.  Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research.

Authors:  Simon C Ling; Thomas Walters; Patrick J McKiernan; Kathleen B Schwarz; Guadalupe Garcia-Tsao; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

7.  The usefulness of distal splenorenal shunt in children with portal hypertension for the treatment of severe thrombocytopenia and leukopenia.

Authors:  Suk-Bae Moon; Sung-Eun Jung; Jong-Won Ha; Kwi-Won Park; Jeong-Kee Seo; Woo-Ki Kim
Journal:  World J Surg       Date:  2008-03       Impact factor: 3.352

8.  Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.

Authors:  Lorena I Cifuentes; Daniela Gattini; Romina Torres-Robles; Juan Cristóbal Gana
Journal:  Cochrane Database Syst Rev       Date:  2021-01-26

9.  Management of portal hypertension in children.

Authors:  Elizabeth Mileti; Philip Rosenthal
Journal:  Curr Gastroenterol Rep       Date:  2011-02

10.  Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.

Authors:  Juan Cristóbal Gana; Lorena I Cifuentes; Daniela Gattini; Luis A Villarroel Del Pino; Alfredo Peña; Romina Torres-Robles
Journal:  Cochrane Database Syst Rev       Date:  2019-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.